nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—CHRM1—Carbachol—glaucoma	0.2	0.27	CbGbCtD
Flavoxate—CHRM1—Pilocarpine—glaucoma	0.186	0.251	CbGbCtD
Flavoxate—CHRM2—Carbachol—glaucoma	0.185	0.249	CbGbCtD
Flavoxate—CHRM2—Pilocarpine—glaucoma	0.172	0.231	CbGbCtD
Flavoxate—Tachycardia—Dipivefrin—glaucoma	0.00381	0.0173	CcSEcCtD
Flavoxate—Vision blurred—Echothiophate—glaucoma	0.00378	0.0171	CcSEcCtD
Flavoxate—Drowsiness—Diclofenamide—glaucoma	0.00314	0.0142	CcSEcCtD
Flavoxate—Vomiting—Physostigmine—glaucoma	0.00292	0.0132	CcSEcCtD
Flavoxate—Drowsiness—Methazolamide—glaucoma	0.00289	0.0131	CcSEcCtD
Flavoxate—Nausea—Physostigmine—glaucoma	0.00273	0.0124	CcSEcCtD
Flavoxate—Tension—Metipranolol—glaucoma	0.00264	0.012	CcSEcCtD
Flavoxate—Nervousness—Metipranolol—glaucoma	0.00261	0.0118	CcSEcCtD
Flavoxate—Vision blurred—Metipranolol—glaucoma	0.00254	0.0115	CcSEcCtD
Flavoxate—Tension—Diclofenamide—glaucoma	0.0024	0.0109	CcSEcCtD
Flavoxate—Nervousness—Diclofenamide—glaucoma	0.00238	0.0108	CcSEcCtD
Flavoxate—Palpitations—Metipranolol—glaucoma	0.00238	0.0108	CcSEcCtD
Flavoxate—Vision blurred—Carteolol—glaucoma	0.00235	0.0106	CcSEcCtD
Flavoxate—Palpitations—Carteolol—glaucoma	0.0022	0.00997	CcSEcCtD
Flavoxate—Leukopenia—Diclofenamide—glaucoma	0.00219	0.00993	CcSEcCtD
Flavoxate—Palpitations—Levobunolol—glaucoma	0.00208	0.00942	CcSEcCtD
Flavoxate—Vision blurred—Latanoprost—glaucoma	0.00206	0.00932	CcSEcCtD
Flavoxate—Vertigo—Methazolamide—glaucoma	0.00203	0.00918	CcSEcCtD
Flavoxate—Leukopenia—Methazolamide—glaucoma	0.00202	0.00914	CcSEcCtD
Flavoxate—Confusional state—Diclofenamide—glaucoma	0.00202	0.00913	CcSEcCtD
Flavoxate—Drowsiness—Acetazolamide—glaucoma	0.002	0.00905	CcSEcCtD
Flavoxate—Somnolence—Metipranolol—glaucoma	0.00195	0.00884	CcSEcCtD
Flavoxate—Confusional state—Levobunolol—glaucoma	0.00194	0.00878	CcSEcCtD
Flavoxate—Drowsiness—Brimonidine—glaucoma	0.00192	0.00868	CcSEcCtD
Flavoxate—Confusional state—Methazolamide—glaucoma	0.00186	0.00841	CcSEcCtD
Flavoxate—Somnolence—Diclofenamide—glaucoma	0.00178	0.00805	CcSEcCtD
Flavoxate—Skin disorder—Latanoprost—glaucoma	0.00173	0.00784	CcSEcCtD
Flavoxate—Tension—Apraclonidine—glaucoma	0.00171	0.00776	CcSEcCtD
Flavoxate—Nervousness—Apraclonidine—glaucoma	0.0017	0.00768	CcSEcCtD
Flavoxate—Tension—Bimatoprost—glaucoma	0.00166	0.00752	CcSEcCtD
Flavoxate—Feeling abnormal—Diclofenamide—glaucoma	0.00165	0.00746	CcSEcCtD
Flavoxate—Vision blurred—Apraclonidine—glaucoma	0.00165	0.00745	CcSEcCtD
Flavoxate—Nervousness—Bimatoprost—glaucoma	0.00164	0.00744	CcSEcCtD
Flavoxate—Somnolence—Methazolamide—glaucoma	0.00164	0.00741	CcSEcCtD
Flavoxate—Vision blurred—Bimatoprost—glaucoma	0.0016	0.00722	CcSEcCtD
Flavoxate—Feeling abnormal—Levobunolol—glaucoma	0.00158	0.00717	CcSEcCtD
Flavoxate—Palpitations—Apraclonidine—glaucoma	0.00154	0.00699	CcSEcCtD
Flavoxate—Urticaria—Levobunolol—glaucoma	0.00153	0.00691	CcSEcCtD
Flavoxate—Vertigo—Bimatoprost—glaucoma	0.00152	0.00689	CcSEcCtD
Flavoxate—Feeling abnormal—Methazolamide—glaucoma	0.00152	0.00687	CcSEcCtD
Flavoxate—Palpitations—Bimatoprost—glaucoma	0.0015	0.00677	CcSEcCtD
Flavoxate—Urticaria—Methazolamide—glaucoma	0.00146	0.00662	CcSEcCtD
Flavoxate—Dry mouth—Apraclonidine—glaucoma	0.00145	0.00658	CcSEcCtD
Flavoxate—Vision blurred—Brimonidine—glaucoma	0.00141	0.0064	CcSEcCtD
Flavoxate—Dry mouth—Bimatoprost—glaucoma	0.00141	0.00638	CcSEcCtD
Flavoxate—Tension—Dorzolamide—glaucoma	0.0014	0.00636	CcSEcCtD
Flavoxate—Leukopenia—Acetazolamide—glaucoma	0.0014	0.00633	CcSEcCtD
Flavoxate—Nervousness—Dorzolamide—glaucoma	0.00139	0.0063	CcSEcCtD
Flavoxate—Skin disorder—Apraclonidine—glaucoma	0.00138	0.00627	CcSEcCtD
Flavoxate—Drowsiness—Clonidine—glaucoma	0.00138	0.00626	CcSEcCtD
Flavoxate—Tension—Brinzolamide—glaucoma	0.00138	0.00625	CcSEcCtD
Flavoxate—Headache—Metipranolol—glaucoma	0.00138	0.00623	CcSEcCtD
Flavoxate—Nervousness—Brinzolamide—glaucoma	0.00137	0.00619	CcSEcCtD
Flavoxate—Vision blurred—Dorzolamide—glaucoma	0.00135	0.00611	CcSEcCtD
Flavoxate—Vision blurred—Travoprost—glaucoma	0.00134	0.00608	CcSEcCtD
Flavoxate—Skin disorder—Bimatoprost—glaucoma	0.00134	0.00608	CcSEcCtD
Flavoxate—Tension—Pilocarpine—glaucoma	0.00133	0.00601	CcSEcCtD
Flavoxate—Vision blurred—Brinzolamide—glaucoma	0.00133	0.00601	CcSEcCtD
Flavoxate—Palpitations—Brimonidine—glaucoma	0.00132	0.006	CcSEcCtD
Flavoxate—Nervousness—Pilocarpine—glaucoma	0.00131	0.00595	CcSEcCtD
Flavoxate—Nausea—Metipranolol—glaucoma	0.0013	0.00591	CcSEcCtD
Flavoxate—Vertigo—Dorzolamide—glaucoma	0.00129	0.00582	CcSEcCtD
Flavoxate—Confusional state—Acetazolamide—glaucoma	0.00129	0.00582	CcSEcCtD
Flavoxate—Vertigo—Travoprost—glaucoma	0.00128	0.0058	CcSEcCtD
Flavoxate—Vision blurred—Pilocarpine—glaucoma	0.00127	0.00577	CcSEcCtD
Flavoxate—Headache—Carteolol—glaucoma	0.00127	0.00577	CcSEcCtD
Flavoxate—Vomiting—Diclofenamide—glaucoma	0.00127	0.00576	CcSEcCtD
Flavoxate—Somnolence—Apraclonidine—glaucoma	0.00127	0.00574	CcSEcCtD
Flavoxate—Palpitations—Dorzolamide—glaucoma	0.00127	0.00573	CcSEcCtD
Flavoxate—Vertigo—Brinzolamide—glaucoma	0.00126	0.00573	CcSEcCtD
Flavoxate—Palpitations—Travoprost—glaucoma	0.00126	0.0057	CcSEcCtD
Flavoxate—Headache—Diclofenamide—glaucoma	0.00125	0.00567	CcSEcCtD
Flavoxate—Dry mouth—Brimonidine—glaucoma	0.00125	0.00565	CcSEcCtD
Flavoxate—Palpitations—Brinzolamide—glaucoma	0.00124	0.00563	CcSEcCtD
Flavoxate—Vomiting—Carbachol—glaucoma	0.00124	0.00562	CcSEcCtD
Flavoxate—Somnolence—Bimatoprost—glaucoma	0.00123	0.00556	CcSEcCtD
Flavoxate—Headache—Carbachol—glaucoma	0.00122	0.00554	CcSEcCtD
Flavoxate—Leukopenia—Pilocarpine—glaucoma	0.00121	0.00548	CcSEcCtD
Flavoxate—Nausea—Carteolol—glaucoma	0.00121	0.00547	CcSEcCtD
Flavoxate—Headache—Levobunolol—glaucoma	0.0012	0.00545	CcSEcCtD
Flavoxate—Palpitations—Pilocarpine—glaucoma	0.0012	0.00541	CcSEcCtD
Flavoxate—Tachycardia—Brimonidine—glaucoma	0.00119	0.00541	CcSEcCtD
Flavoxate—Dry mouth—Dorzolamide—glaucoma	0.00119	0.0054	CcSEcCtD
Flavoxate—Skin disorder—Brimonidine—glaucoma	0.00119	0.00538	CcSEcCtD
Flavoxate—Nausea—Diclofenamide—glaucoma	0.00119	0.00538	CcSEcCtD
Flavoxate—Dry mouth—Travoprost—glaucoma	0.00119	0.00537	CcSEcCtD
Flavoxate—Antrafenine—PTGS2—glaucoma	0.00118	1	CrCbGaD
Flavoxate—Confusional state—Dorzolamide—glaucoma	0.00118	0.00533	CcSEcCtD
Flavoxate—Feeling abnormal—Apraclonidine—glaucoma	0.00117	0.00532	CcSEcCtD
Flavoxate—Dry mouth—Brinzolamide—glaucoma	0.00117	0.00531	CcSEcCtD
Flavoxate—Vomiting—Methazolamide—glaucoma	0.00117	0.0053	CcSEcCtD
Flavoxate—Nausea—Carbachol—glaucoma	0.00116	0.00525	CcSEcCtD
Flavoxate—Headache—Methazolamide—glaucoma	0.00115	0.00522	CcSEcCtD
Flavoxate—Nausea—Levobunolol—glaucoma	0.00114	0.00517	CcSEcCtD
Flavoxate—Tachycardia—Travoprost—glaucoma	0.00114	0.00514	CcSEcCtD
Flavoxate—Somnolence—Acetazolamide—glaucoma	0.00113	0.00513	CcSEcCtD
Flavoxate—Skin disorder—Travoprost—glaucoma	0.00113	0.00512	CcSEcCtD
Flavoxate—Tachycardia—Brinzolamide—glaucoma	0.00112	0.00508	CcSEcCtD
Flavoxate—Headache—Latanoprost—glaucoma	0.00112	0.00506	CcSEcCtD
Flavoxate—Skin disorder—Brinzolamide—glaucoma	0.00112	0.00505	CcSEcCtD
Flavoxate—Confusional state—Pilocarpine—glaucoma	0.00111	0.00504	CcSEcCtD
Flavoxate—Nausea—Methazolamide—glaucoma	0.00109	0.00495	CcSEcCtD
Flavoxate—Somnolence—Brimonidine—glaucoma	0.00109	0.00492	CcSEcCtD
Flavoxate—Tachycardia—Pilocarpine—glaucoma	0.00108	0.00488	CcSEcCtD
Flavoxate—Tension—Clonidine—glaucoma	0.00106	0.0048	CcSEcCtD
Flavoxate—Feeling abnormal—Acetazolamide—glaucoma	0.00105	0.00476	CcSEcCtD
Flavoxate—Nervousness—Clonidine—glaucoma	0.00105	0.00475	CcSEcCtD
Flavoxate—Somnolence—Dorzolamide—glaucoma	0.00104	0.0047	CcSEcCtD
Flavoxate—Somnolence—Brinzolamide—glaucoma	0.00102	0.00462	CcSEcCtD
Flavoxate—Vision blurred—Clonidine—glaucoma	0.00102	0.00461	CcSEcCtD
Flavoxate—Urticaria—Acetazolamide—glaucoma	0.00101	0.00458	CcSEcCtD
Flavoxate—Somnolence—Pilocarpine—glaucoma	0.000981	0.00444	CcSEcCtD
Flavoxate—Feeling abnormal—Dorzolamide—glaucoma	0.000963	0.00436	CcSEcCtD
Flavoxate—Feeling abnormal—Travoprost—glaucoma	0.000959	0.00434	CcSEcCtD
Flavoxate—Palpitations—Clonidine—glaucoma	0.000955	0.00432	CcSEcCtD
Flavoxate—Feeling abnormal—Brinzolamide—glaucoma	0.000947	0.00429	CcSEcCtD
Flavoxate—Urticaria—Dorzolamide—glaucoma	0.000928	0.0042	CcSEcCtD
Flavoxate—Tension—Betaxolol—glaucoma	0.000923	0.00418	CcSEcCtD
Flavoxate—Nervousness—Betaxolol—glaucoma	0.000913	0.00414	CcSEcCtD
Flavoxate—Urticaria—Brinzolamide—glaucoma	0.000913	0.00413	CcSEcCtD
Flavoxate—Feeling abnormal—Pilocarpine—glaucoma	0.00091	0.00412	CcSEcCtD
Flavoxate—Vomiting—Apraclonidine—glaucoma	0.000906	0.0041	CcSEcCtD
Flavoxate—Dry mouth—Clonidine—glaucoma	0.000899	0.00407	CcSEcCtD
Flavoxate—Headache—Apraclonidine—glaucoma	0.000893	0.00404	CcSEcCtD
Flavoxate—Confusional state—Clonidine—glaucoma	0.000889	0.00402	CcSEcCtD
Flavoxate—Vision blurred—Betaxolol—glaucoma	0.000886	0.00401	CcSEcCtD
Flavoxate—Headache—Bimatoprost—glaucoma	0.000866	0.00392	CcSEcCtD
Flavoxate—Tachycardia—Clonidine—glaucoma	0.00086	0.0039	CcSEcCtD
Flavoxate—Skin disorder—Clonidine—glaucoma	0.000856	0.00388	CcSEcCtD
Flavoxate—Nausea—Apraclonidine—glaucoma	0.000846	0.00383	CcSEcCtD
Flavoxate—Vertigo—Betaxolol—glaucoma	0.000845	0.00383	CcSEcCtD
Flavoxate—Palpitations—Betaxolol—glaucoma	0.000831	0.00376	CcSEcCtD
Flavoxate—Nausea—Bimatoprost—glaucoma	0.000821	0.00372	CcSEcCtD
Flavoxate—Vomiting—Acetazolamide—glaucoma	0.00081	0.00367	CcSEcCtD
Flavoxate—Headache—Acetazolamide—glaucoma	0.000799	0.00362	CcSEcCtD
Flavoxate—Somnolence—Clonidine—glaucoma	0.000784	0.00355	CcSEcCtD
Flavoxate—Dry mouth—Betaxolol—glaucoma	0.000783	0.00355	CcSEcCtD
Flavoxate—Confusional state—Betaxolol—glaucoma	0.000774	0.0035	CcSEcCtD
Flavoxate—Headache—Brimonidine—glaucoma	0.000766	0.00347	CcSEcCtD
Flavoxate—Nausea—Acetazolamide—glaucoma	0.000757	0.00343	CcSEcCtD
Flavoxate—Tension—Timolol—glaucoma	0.000754	0.00341	CcSEcCtD
Flavoxate—Tachycardia—Betaxolol—glaucoma	0.000749	0.00339	CcSEcCtD
Flavoxate—Nervousness—Timolol—glaucoma	0.000746	0.00338	CcSEcCtD
Flavoxate—Skin disorder—Betaxolol—glaucoma	0.000746	0.00338	CcSEcCtD
Flavoxate—Vomiting—Dorzolamide—glaucoma	0.000743	0.00336	CcSEcCtD
Flavoxate—Headache—Dorzolamide—glaucoma	0.000732	0.00331	CcSEcCtD
Flavoxate—Vomiting—Brinzolamide—glaucoma	0.00073	0.00331	CcSEcCtD
Flavoxate—Headache—Travoprost—glaucoma	0.000729	0.0033	CcSEcCtD
Flavoxate—Nausea—Brimonidine—glaucoma	0.000727	0.00329	CcSEcCtD
Flavoxate—Feeling abnormal—Clonidine—glaucoma	0.000727	0.00329	CcSEcCtD
Flavoxate—Vision blurred—Timolol—glaucoma	0.000724	0.00328	CcSEcCtD
Flavoxate—Headache—Brinzolamide—glaucoma	0.00072	0.00326	CcSEcCtD
Flavoxate—Vomiting—Pilocarpine—glaucoma	0.000702	0.00318	CcSEcCtD
Flavoxate—Urticaria—Clonidine—glaucoma	0.0007	0.00317	CcSEcCtD
Flavoxate—Nausea—Dorzolamide—glaucoma	0.000694	0.00314	CcSEcCtD
Flavoxate—Headache—Pilocarpine—glaucoma	0.000692	0.00313	CcSEcCtD
Flavoxate—Nausea—Travoprost—glaucoma	0.000691	0.00313	CcSEcCtD
Flavoxate—Vertigo—Timolol—glaucoma	0.00069	0.00313	CcSEcCtD
Flavoxate—Nausea—Brinzolamide—glaucoma	0.000682	0.00309	CcSEcCtD
Flavoxate—Palpitations—Timolol—glaucoma	0.000679	0.00307	CcSEcCtD
Flavoxate—Nausea—Pilocarpine—glaucoma	0.000656	0.00297	CcSEcCtD
Flavoxate—Dry mouth—Timolol—glaucoma	0.00064	0.0029	CcSEcCtD
Flavoxate—Feeling abnormal—Betaxolol—glaucoma	0.000633	0.00286	CcSEcCtD
Flavoxate—Confusional state—Timolol—glaucoma	0.000632	0.00286	CcSEcCtD
Flavoxate—Urticaria—Betaxolol—glaucoma	0.00061	0.00276	CcSEcCtD
Flavoxate—Skin disorder—Timolol—glaucoma	0.000609	0.00276	CcSEcCtD
Flavoxate—Vomiting—Clonidine—glaucoma	0.000561	0.00254	CcSEcCtD
Flavoxate—Somnolence—Timolol—glaucoma	0.000557	0.00252	CcSEcCtD
Flavoxate—Headache—Clonidine—glaucoma	0.000552	0.0025	CcSEcCtD
Flavoxate—Nausea—Clonidine—glaucoma	0.000524	0.00237	CcSEcCtD
Flavoxate—Feeling abnormal—Timolol—glaucoma	0.000517	0.00234	CcSEcCtD
Flavoxate—Urticaria—Timolol—glaucoma	0.000498	0.00226	CcSEcCtD
Flavoxate—Vomiting—Betaxolol—glaucoma	0.000488	0.00221	CcSEcCtD
Flavoxate—Headache—Betaxolol—glaucoma	0.000481	0.00218	CcSEcCtD
Flavoxate—Nausea—Betaxolol—glaucoma	0.000456	0.00206	CcSEcCtD
Flavoxate—Vomiting—Timolol—glaucoma	0.000399	0.00181	CcSEcCtD
Flavoxate—Headache—Timolol—glaucoma	0.000393	0.00178	CcSEcCtD
Flavoxate—Nausea—Timolol—glaucoma	0.000372	0.00169	CcSEcCtD
Flavoxate—PDE4B—Signaling Pathways—PTGFR—glaucoma	7.58e-05	0.00217	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	7.55e-05	0.00216	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NTRK2—glaucoma	7.52e-05	0.00216	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NCK2—glaucoma	7.49e-05	0.00215	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—C3—glaucoma	7.46e-05	0.00214	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	7.42e-05	0.00213	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	7.39e-05	0.00212	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—SMO—glaucoma	7.34e-05	0.0021	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NGFR—glaucoma	7.24e-05	0.00208	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NGFR—glaucoma	7.24e-05	0.00208	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	7.08e-05	0.00203	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NTRK2—glaucoma	6.99e-05	0.002	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—SMO—glaucoma	6.99e-05	0.002	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NTRK1—glaucoma	6.88e-05	0.00197	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NTRK1—glaucoma	6.88e-05	0.00197	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—OPN4—glaucoma	6.74e-05	0.00193	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RPTOR—glaucoma	6.73e-05	0.00193	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—OPN4—glaucoma	6.65e-05	0.00191	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NCK2—glaucoma	6.52e-05	0.00187	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	6.51e-05	0.00187	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—SMO—glaucoma	6.47e-05	0.00185	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NGFR—glaucoma	6.46e-05	0.00185	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	6.43e-05	0.00184	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RPTOR—glaucoma	6.41e-05	0.00184	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HDAC9—glaucoma	6.37e-05	0.00183	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CDKN2B—glaucoma	6.34e-05	0.00182	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CDKN2B—glaucoma	6.34e-05	0.00182	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	6.33e-05	0.00181	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NCK2—glaucoma	6.21e-05	0.00178	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NTRK1—glaucoma	6.13e-05	0.00176	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—EDN1—glaucoma	6.13e-05	0.00176	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—OPN4—glaucoma	6.12e-05	0.00175	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EDN1—glaucoma	6.08e-05	0.00174	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EDN1—glaucoma	6.08e-05	0.00174	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	6.07e-05	0.00174	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—OPN4—glaucoma	6.04e-05	0.00173	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NGFR—glaucoma	6e-05	0.00172	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	5.99e-05	0.00172	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RPTOR—glaucoma	5.93e-05	0.0017	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—FAS—glaucoma	5.92e-05	0.0017	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NCK2—glaucoma	5.74e-05	0.00165	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NTRK1—glaucoma	5.7e-05	0.00163	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CDKN2B—glaucoma	5.65e-05	0.00162	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NGF—glaucoma	5.59e-05	0.0016	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NGF—glaucoma	5.59e-05	0.0016	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EDN1—glaucoma	5.56e-05	0.00159	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HDAC9—glaucoma	5.54e-05	0.00159	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PTGFR—glaucoma	5.51e-05	0.00158	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PTGFR—glaucoma	5.44e-05	0.00156	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EDN1—glaucoma	5.42e-05	0.00155	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—SMO—glaucoma	5.41e-05	0.00155	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—C3—glaucoma	5.35e-05	0.00153	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—SMO—glaucoma	5.34e-05	0.00153	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—EDN1—glaucoma	5.33e-05	0.00153	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—C3—glaucoma	5.32e-05	0.00152	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—C3—glaucoma	5.32e-05	0.00152	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HDAC9—glaucoma	5.28e-05	0.00151	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CDKN2B—glaucoma	5.25e-05	0.00151	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LRP12—glaucoma	5.22e-05	0.00149	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LRP12—glaucoma	5.15e-05	0.00148	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—C3—glaucoma	5.08e-05	0.00146	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—EDN1—glaucoma	5.08e-05	0.00145	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EDN1—glaucoma	5.04e-05	0.00144	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SMO—glaucoma	4.98e-05	0.00143	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NGF—glaucoma	4.98e-05	0.00143	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—APOE—glaucoma	4.95e-05	0.00142	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—APOE—glaucoma	4.95e-05	0.00142	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CAV1—glaucoma	4.9e-05	0.00141	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CAV1—glaucoma	4.9e-05	0.00141	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HDAC9—glaucoma	4.88e-05	0.0014	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—C3—glaucoma	4.86e-05	0.00139	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EDN1—glaucoma	4.84e-05	0.00139	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—C3—glaucoma	4.74e-05	0.00136	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—EDN1—glaucoma	4.7e-05	0.00135	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.69e-05	0.00134	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—FN1—glaucoma	4.67e-05	0.00134	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—FN1—glaucoma	4.67e-05	0.00134	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—C3—glaucoma	4.66e-05	0.00133	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NGF—glaucoma	4.63e-05	0.00133	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	4.63e-05	0.00133	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—BAD—glaucoma	4.61e-05	0.00132	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—BAD—glaucoma	4.61e-05	0.00132	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EDN1—glaucoma	4.61e-05	0.00132	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NTRK2—glaucoma	4.56e-05	0.00131	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—C3—glaucoma	4.43e-05	0.00127	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—APOE—glaucoma	4.41e-05	0.00126	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—C3—glaucoma	4.4e-05	0.00126	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CAV1—glaucoma	4.37e-05	0.00125	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SMO—glaucoma	4.34e-05	0.00124	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EDN1—glaucoma	4.26e-05	0.00122	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—C3—glaucoma	4.23e-05	0.00121	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—FN1—glaucoma	4.16e-05	0.00119	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SMO—glaucoma	4.13e-05	0.00118	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—BAD—glaucoma	4.11e-05	0.00118	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—C3—glaucoma	4.1e-05	0.00118	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—APOE—glaucoma	4.1e-05	0.00118	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.09e-05	0.00117	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CAV1—glaucoma	4.06e-05	0.00116	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.04e-05	0.00116	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—C3—glaucoma	4.03e-05	0.00115	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NTRK2—glaucoma	3.97e-05	0.00114	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NGFR—glaucoma	3.91e-05	0.00112	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—FN1—glaucoma	3.87e-05	0.00111	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—BAD—glaucoma	3.82e-05	0.0011	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SMO—glaucoma	3.82e-05	0.0011	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NTRK2—glaucoma	3.78e-05	0.00108	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—C3—glaucoma	3.73e-05	0.00107	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NTRK1—glaucoma	3.72e-05	0.00106	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NOS3—glaucoma	3.71e-05	0.00106	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NOS3—glaucoma	3.71e-05	0.00106	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—OPN4—glaucoma	3.61e-05	0.00104	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—EDN1—glaucoma	3.57e-05	0.00102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—OPN4—glaucoma	3.57e-05	0.00102	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.55e-05	0.00102	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—EDN1—glaucoma	3.52e-05	0.00101	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NTRK2—glaucoma	3.49e-05	0.001	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CDKN2B—glaucoma	3.42e-05	0.000981	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NGFR—glaucoma	3.4e-05	0.000976	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HEYL—glaucoma	3.36e-05	0.000963	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HEYL—glaucoma	3.32e-05	0.000951	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NOS3—glaucoma	3.3e-05	0.000947	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EDN1—glaucoma	3.29e-05	0.000942	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTGFR—glaucoma	3.25e-05	0.000933	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NGFR—glaucoma	3.24e-05	0.000929	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NTRK1—glaucoma	3.23e-05	0.000927	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTGFR—glaucoma	3.21e-05	0.000921	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CDKN1B—glaucoma	3.21e-05	0.00092	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CDKN1B—glaucoma	3.21e-05	0.00092	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—C3—glaucoma	3.12e-05	0.000894	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NTRK1—glaucoma	3.08e-05	0.000882	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—C3—glaucoma	3.08e-05	0.000882	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NOS3—glaucoma	3.07e-05	0.00088	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	3.04e-05	0.000871	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NGF—glaucoma	3.02e-05	0.000865	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NGFR—glaucoma	3e-05	0.000859	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CDKN2B—glaucoma	2.98e-05	0.000854	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MMP9—glaucoma	2.97e-05	0.000852	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MMP9—glaucoma	2.97e-05	0.000852	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—C3—glaucoma	2.87e-05	0.000823	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CDKN1B—glaucoma	2.86e-05	0.00082	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EDN1—glaucoma	2.86e-05	0.00082	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NTRK1—glaucoma	2.85e-05	0.000816	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDKN2B—glaucoma	2.84e-05	0.000813	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—SMO—glaucoma	2.78e-05	0.000796	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—SMO—glaucoma	2.74e-05	0.000786	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EDN1—glaucoma	2.72e-05	0.00078	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APOE—glaucoma	2.67e-05	0.000766	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—VEGFA—glaucoma	2.67e-05	0.000765	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—VEGFA—glaucoma	2.67e-05	0.000765	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CDKN1B—glaucoma	2.66e-05	0.000763	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MMP9—glaucoma	2.65e-05	0.00076	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CAV1—glaucoma	2.65e-05	0.000759	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NGF—glaucoma	2.63e-05	0.000753	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDKN2B—glaucoma	2.63e-05	0.000752	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RPTOR—glaucoma	2.55e-05	0.00073	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—FN1—glaucoma	2.52e-05	0.000722	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EDN1—glaucoma	2.52e-05	0.000722	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RPTOR—glaucoma	2.51e-05	0.00072	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NGF—glaucoma	2.5e-05	0.000717	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—C3—glaucoma	2.5e-05	0.000716	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—BAD—glaucoma	2.49e-05	0.000714	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NCK2—glaucoma	2.47e-05	0.000707	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MMP9—glaucoma	2.46e-05	0.000706	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NCK2—glaucoma	2.43e-05	0.000698	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—VEGFA—glaucoma	2.38e-05	0.000682	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—C3—glaucoma	2.38e-05	0.000682	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APOE—glaucoma	2.33e-05	0.000667	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NGF—glaucoma	2.32e-05	0.000663	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CAV1—glaucoma	2.3e-05	0.000661	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—glaucoma	2.22e-05	0.000635	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APOE—glaucoma	2.21e-05	0.000635	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—VEGFA—glaucoma	2.21e-05	0.000634	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—C3—glaucoma	2.2e-05	0.000631	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CAV1—glaucoma	2.19e-05	0.000629	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FN1—glaucoma	2.19e-05	0.000629	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—BAD—glaucoma	2.17e-05	0.000621	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HDAC9—glaucoma	2.1e-05	0.000601	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FN1—glaucoma	2.09e-05	0.000598	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HDAC9—glaucoma	2.07e-05	0.000593	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—BAD—glaucoma	2.06e-05	0.000591	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APOE—glaucoma	2.05e-05	0.000587	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CAV1—glaucoma	2.03e-05	0.000582	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—glaucoma	2.02e-05	0.000578	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—glaucoma	2.02e-05	0.000578	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—EDN1—glaucoma	2.02e-05	0.000578	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOS3—glaucoma	2e-05	0.000574	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.99e-05	0.000571	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FN1—glaucoma	1.93e-05	0.000554	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BAD—glaucoma	1.91e-05	0.000547	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.83e-05	0.000525	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.81e-05	0.000518	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—glaucoma	1.8e-05	0.000516	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—C3—glaucoma	1.76e-05	0.000505	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOS3—glaucoma	1.74e-05	0.000499	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—C3—glaucoma	1.74e-05	0.000498	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CDKN1B—glaucoma	1.73e-05	0.000497	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—glaucoma	1.67e-05	0.000479	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOS3—glaucoma	1.66e-05	0.000475	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SMO—glaucoma	1.64e-05	0.00047	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SMO—glaucoma	1.62e-05	0.000464	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—glaucoma	1.61e-05	0.00046	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—C3—glaucoma	1.6e-05	0.000459	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—C3—glaucoma	1.58e-05	0.000453	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOS3—glaucoma	1.53e-05	0.00044	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CDKN1B—glaucoma	1.51e-05	0.000433	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK2—glaucoma	1.5e-05	0.00043	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK2—glaucoma	1.48e-05	0.000425	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—glaucoma	1.44e-05	0.000413	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDKN1B—glaucoma	1.44e-05	0.000412	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—glaucoma	1.4e-05	0.000401	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—glaucoma	1.33e-05	0.000381	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDKN1B—glaucoma	1.33e-05	0.000381	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NGFR—glaucoma	1.29e-05	0.000369	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NGFR—glaucoma	1.27e-05	0.000364	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—glaucoma	1.26e-05	0.00036	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—glaucoma	1.23e-05	0.000353	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK1—glaucoma	1.22e-05	0.000351	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK1—glaucoma	1.21e-05	0.000346	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—glaucoma	1.2e-05	0.000343	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN2B—glaucoma	1.13e-05	0.000323	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN2B—glaucoma	1.11e-05	0.000319	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—glaucoma	1.11e-05	0.000317	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—glaucoma	1.09e-05	0.000312	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDN1—glaucoma	1.08e-05	0.00031	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDN1—glaucoma	1.07e-05	0.000306	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NGF—glaucoma	9.94e-06	0.000285	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NGF—glaucoma	9.82e-06	0.000281	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—glaucoma	9.49e-06	0.000272	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—C3—glaucoma	9.45e-06	0.000271	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—C3—glaucoma	9.33e-06	0.000267	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—glaucoma	9.03e-06	0.000259	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOE—glaucoma	8.8e-06	0.000252	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CAV1—glaucoma	8.72e-06	0.00025	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOE—glaucoma	8.69e-06	0.000249	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CAV1—glaucoma	8.61e-06	0.000247	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—glaucoma	8.36e-06	0.000239	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FN1—glaucoma	8.3e-06	0.000238	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BAD—glaucoma	8.2e-06	0.000235	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FN1—glaucoma	8.19e-06	0.000235	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BAD—glaucoma	8.09e-06	0.000232	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOS3—glaucoma	6.59e-06	0.000189	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOS3—glaucoma	6.51e-06	0.000187	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN1B—glaucoma	5.71e-06	0.000164	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN1B—glaucoma	5.64e-06	0.000162	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—glaucoma	5.29e-06	0.000152	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—glaucoma	5.22e-06	0.00015	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—glaucoma	4.75e-06	0.000136	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—glaucoma	4.69e-06	0.000134	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—glaucoma	3.59e-06	0.000103	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—glaucoma	3.54e-06	0.000102	CbGpPWpGaD
